|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:CAPZB-NBL1 (FusionGDB2 ID:HG832TG4681) |
Fusion Gene Summary for CAPZB-NBL1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CAPZB-NBL1 | Fusion gene ID: hg832tg4681 | Hgene | Tgene | Gene symbol | CAPZB | NBL1 | Gene ID | 832 | 4681 |
| Gene name | capping actin protein of muscle Z-line subunit beta | NBL1, DAN family BMP antagonist | |
| Synonyms | CAPB|CAPPB|CAPZ | D1S1733E|DAN|DAND1|NB|NO3 | |
| Cytomap | ('CAPZB')('NBL1') 1p36.13 | 1p36.13 | |
| Type of gene | protein-coding | protein-coding | |
| Description | F-actin-capping protein subunit betacapZ betacapping actin protein of muscle Z-line beta subunitcapping protein (actin filament) muscle Z-line, betaepididymis secretory sperm binding protein | neuroblastoma suppressor of tumorigenicity 1DAN domain family member 1differential screening-selected gene aberrant in neuroblastomaneuroblastoma 1, DAN family BMP antagonistneuroblastoma candidate region, suppression of tumorigenicity 1 | |
| Modification date | 20200320 | 20200313 | |
| UniProtAcc | P47756 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000264202, ENST00000264203, ENST00000375142, ENST00000375144, ENST00000401084, ENST00000433834, ENST00000482808, | ||
| Fusion gene scores | * DoF score | 20 X 22 X 11=4840 | 1 X 1 X 1=1 |
| # samples | 29 | 1 | |
| ** MAII score | log2(29/4840*10)=-4.06088224214702 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(1/1*10)=3.32192809488736 | |
| Context | PubMed: CAPZB [Title/Abstract] AND NBL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | CAPZB(19705034)-NBL1(19981505), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | CAPZB-NBL1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. CAPZB-NBL1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | NBL1 | GO:0030514 | negative regulation of BMP signaling pathway | 23063586 |
| Tgene | NBL1 | GO:0038098 | sequestering of BMP from receptor via BMP binding | 23063586 |
| Fusion gene breakpoints across CAPZB (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across NBL1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | GBM | TCGA-06-0141-01A | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
Top |
Fusion Gene ORF analysis for CAPZB-NBL1 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000264202 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000264202 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000264203 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000264203 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000375142 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000375142 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000375144 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000375144 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000401084 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000401084 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000433834 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5CDS-5UTR | ENST00000433834 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5UTR-3CDS | ENST00000482808 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5UTR-5UTR | ENST00000482808 | ENST00000375136 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| 5UTR-5UTR | ENST00000482808 | ENST00000548815 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| In-frame | ENST00000264202 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| In-frame | ENST00000264203 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| In-frame | ENST00000375142 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| In-frame | ENST00000375144 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| In-frame | ENST00000401084 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| In-frame | ENST00000433834 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000401084 | CAPZB | chr1 | 19705034 | - | ENST00000289749 | NBL1 | chr1 | 19981505 | + | 1028 | 463 | 134 | 1027 | 298 |
| ENST00000264203 | CAPZB | chr1 | 19705034 | - | ENST00000289749 | NBL1 | chr1 | 19981505 | + | 1466 | 901 | 494 | 1465 | 324 |
| ENST00000375142 | CAPZB | chr1 | 19705034 | - | ENST00000289749 | NBL1 | chr1 | 19981505 | + | 941 | 376 | 47 | 940 | 298 |
| ENST00000433834 | CAPZB | chr1 | 19705034 | - | ENST00000289749 | NBL1 | chr1 | 19981505 | + | 1366 | 801 | 340 | 1365 | 342 |
| ENST00000264202 | CAPZB | chr1 | 19705034 | - | ENST00000289749 | NBL1 | chr1 | 19981505 | + | 943 | 378 | 49 | 942 | 298 |
| ENST00000375144 | CAPZB | chr1 | 19705034 | - | ENST00000289749 | NBL1 | chr1 | 19981505 | + | 892 | 327 | 13 | 891 | 293 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000401084 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + | 0.008428533 | 0.9915714 |
| ENST00000264203 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + | 0.014507001 | 0.985493 |
| ENST00000375142 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + | 0.010402197 | 0.9895978 |
| ENST00000433834 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + | 0.006069831 | 0.9939302 |
| ENST00000264202 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + | 0.010640723 | 0.98935926 |
| ENST00000375144 | ENST00000289749 | CAPZB | chr1 | 19705034 | - | NBL1 | chr1 | 19981505 | + | 0.013896948 | 0.98610306 |
Top |
Fusion Genomic Features for CAPZB-NBL1 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| CAPZB | chr1 | 19705033 | - | NBL1 | chr1 | 19981504 | + | 3.07E-07 | 0.99999964 |
| CAPZB | chr1 | 19705033 | - | NBL1 | chr1 | 19981504 | + | 3.07E-07 | 0.99999964 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
 |
Top |
Fusion Protein Features for CAPZB-NBL1 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr1:19705034/chr1:19981505) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CAPZB | . |
| FUNCTION: F-actin-capping proteins bind in a Ca(2+)-independent manner to the fast growing ends of actin filaments (barbed end) thereby blocking the exchange of subunits at these ends. Unlike other capping proteins (such as gelsolin and severin), these proteins do not sever actin filaments. Plays a role in the regulation of cell morphology and cytoskeletal organization. {ECO:0000269|PubMed:21834987}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Tgene | NBL1 | chr1:19705034 | chr1:19981505 | ENST00000289749 | 0 | 4 | 142_172 | 28 | 217.0 | Compositional bias | Note=Pro-rich | |
| Tgene | NBL1 | chr1:19705034 | chr1:19981505 | ENST00000375136 | 0 | 4 | 142_172 | 0 | 182.0 | Compositional bias | Note=Pro-rich | |
| Tgene | NBL1 | chr1:19705034 | chr1:19981505 | ENST00000548815 | 0 | 4 | 142_172 | 0 | 181.0 | Compositional bias | Note=Pro-rich | |
| Tgene | NBL1 | chr1:19705034 | chr1:19981505 | ENST00000289749 | 0 | 4 | 35_124 | 28 | 217.0 | Domain | Note=CTCK | |
| Tgene | NBL1 | chr1:19705034 | chr1:19981505 | ENST00000375136 | 0 | 4 | 35_124 | 0 | 182.0 | Domain | Note=CTCK | |
| Tgene | NBL1 | chr1:19705034 | chr1:19981505 | ENST00000548815 | 0 | 4 | 35_124 | 0 | 181.0 | Domain | Note=CTCK |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CAPZB-NBL1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >13006_13006_1_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000264202_NBL1_chr1_19981505_ENST00000289749_length(transcript)=943nt_BP=378nt GGGGAGAGCCACTGACGCCGGGACCGGGACCGCCGCCGCCGCCGCCACCATGAGTGATCAGCAGCTGGACTGTGCCTTGGACCTAATGAG GCGCCTGCCTCCCCAGCAAATCGAGAAAAACCTCAGCGACCTGATCGACCTGGTCCCCAGTCTATGTGAGGATCTCCTGTCTTCTGTTGA CCAGCCACTGAAAATTGCCAGAGACAAGGTGGTGGGAAAGGATTACCTTTTGTGTGACTACAACAGAGATGGGGACTCCTATAGGTCACC ATGGAGTAACAAGTATGACCCTCCCTTGGAGGATGGGGCCATGCCGTCAGCTCGGCTGAGAAAGCTGGAGGTGGAAGCCAACAATGCCTT TGACCAGTATCGAGACCTGGCTCTGGAGGCCACGGGCATGATGCTTCGGGTCCTGGTGGGGGCTGTCCTCCCTGCCATGCTACTGGCTGC CCCACCACCCATCAACAAGCTGGCACTGTTCCCAGATAAGAGTGCCTGGTGCGAAGCCAAGAACATCACCCAGATCGTGGGCCACAGCGG CTGTGAGGCCAAGTCCATCCAGAACAGGGCGTGCCTAGGACAGTGCTTCAGCTACAGCGTCCCCAACACCTTCCCACAGTCCACAGAGTC CCTGGTTCACTGTGACTCCTGCATGCCAGCCCAGTCCATGTGGGAGATTGTGACGCTGGAGTGCCCGGGCCACGAGGAGGTGCCCAGGGT GGACAAGCTGGTGGAGAAGATCCTGCACTGTAGCTGCCAGGCCTGCGGCAAGGAGCCTAGTCACGAGGGGCTGAGCGTCTATGTGCAGGG CGAGGACGGGCCGGGATCCCAGCCCGGCACCCACCCTCACCCCCATCCCCACCCCCATCCTGGCGGGCAGACCCCTGAGCCCGAGGACCC >13006_13006_1_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000264202_NBL1_chr1_19981505_ENST00000289749_length(amino acids)=298AA_BP=110 MSDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPS ARLRKLEVEANNAFDQYRDLALEATGMMLRVLVGAVLPAMLLAAPPPINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCF SYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKILHCSCQACGKEPSHEGLSVYVQGEDGPGSQPGTHPHPHP -------------------------------------------------------------- >13006_13006_2_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000264203_NBL1_chr1_19981505_ENST00000289749_length(transcript)=1466nt_BP=901nt GTGGAAGCGCCGGGCCCTGCTGCGGGGGGGAGAGCCACTGACGCCGGGACCGGGACCGCCGCCGCCGCCGCCACCATGCTCCATGCCTGA CCGTGACTCGCATCTCGCCAGGCCAGTGCATTTCCTCTTCTGGCTGTCATCGGAATTTTCAAGTGTCAAGACCCCACTTTGTTCCTGTTG TCCTGGTTCCGGCTTTGGGAAGCATGACCTTTCAGGCCTGCTCAGAGACACCGCAGTGCACTTTGTGCGTTATCAGCCTTACAGAGACTC TACGGTCAGGAGTTTTTGTGGCAATGGAACTGCTGGGGTTTCATCTGCAAATGAAAACCATCTGGCCAGCTGCTTGGGTCAGATGGAAAC CAGATGGGAGAAGTCAGGAGCGGGCAGCGAGCAGCCTGGGGCAGCGTCCCTAGTCACGTCATGTTTCCACTTCCTCTTGCCCCCTCGCCT CCCCTGCCTGCAAAACGATTGTTATTAACCCATCACCTCCTCCAATGCCCAGGCAGTTCCAGGATACAGGGTTCTCTCGCCCAGGCCTTG GCCAGCCCAGAAGATGTGACCCAGAACCTAGAAAGAGTGATCAGCAGCTGGACTGTGCCTTGGACCTAATGAGGCGCCTGCCTCCCCAGC AAATCGAGAAAAACCTCAGCGACCTGATCGACCTGGTCCCCAGTCTATGTGAGGATCTCCTGTCTTCTGTTGACCAGCCACTGAAAATTG CCAGAGACAAGGTGGTGGGAAAGGATTACCTTTTGTGTGACTACAACAGAGATGGGGACTCCTATAGGTCACCATGGAGTAACAAGTATG ACCCTCCCTTGGAGGATGGGGCCATGCCGTCAGCTCGGCTGAGAAAGCTGGAGGTGGAAGCCAACAATGCCTTTGACCAGTATCGAGACC TGGCTCTGGAGGCCACGGGCATGATGCTTCGGGTCCTGGTGGGGGCTGTCCTCCCTGCCATGCTACTGGCTGCCCCACCACCCATCAACA AGCTGGCACTGTTCCCAGATAAGAGTGCCTGGTGCGAAGCCAAGAACATCACCCAGATCGTGGGCCACAGCGGCTGTGAGGCCAAGTCCA TCCAGAACAGGGCGTGCCTAGGACAGTGCTTCAGCTACAGCGTCCCCAACACCTTCCCACAGTCCACAGAGTCCCTGGTTCACTGTGACT CCTGCATGCCAGCCCAGTCCATGTGGGAGATTGTGACGCTGGAGTGCCCGGGCCACGAGGAGGTGCCCAGGGTGGACAAGCTGGTGGAGA AGATCCTGCACTGTAGCTGCCAGGCCTGCGGCAAGGAGCCTAGTCACGAGGGGCTGAGCGTCTATGTGCAGGGCGAGGACGGGCCGGGAT CCCAGCCCGGCACCCACCCTCACCCCCATCCCCACCCCCATCCTGGCGGGCAGACCCCTGAGCCCGAGGACCCCCCTGGGGCCCCCCACA >13006_13006_2_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000264203_NBL1_chr1_19981505_ENST00000289749_length(amino acids)=324AA_BP=136 MPRQFQDTGFSRPGLGQPRRCDPEPRKSDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDY NRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLALEATGMMLRVLVGAVLPAMLLAAPPPINKLALFPDKSAWCEAK NITQIVGHSGCEAKSIQNRACLGQCFSYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKILHCSCQACGKEPS -------------------------------------------------------------- >13006_13006_3_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000375142_NBL1_chr1_19981505_ENST00000289749_length(transcript)=941nt_BP=376nt GGAGAGCCACTGACGCCGGGACCGGGACCGCCGCCGCCGCCGCCACCATGAGTGATCAGCAGCTGGACTGTGCCTTGGACCTAATGAGGC GCCTGCCTCCCCAGCAAATCGAGAAAAACCTCAGCGACCTGATCGACCTGGTCCCCAGTCTATGTGAGGATCTCCTGTCTTCTGTTGACC AGCCACTGAAAATTGCCAGAGACAAGGTGGTGGGAAAGGATTACCTTTTGTGTGACTACAACAGAGATGGGGACTCCTATAGGTCACCAT GGAGTAACAAGTATGACCCTCCCTTGGAGGATGGGGCCATGCCGTCAGCTCGGCTGAGAAAGCTGGAGGTGGAAGCCAACAATGCCTTTG ACCAGTATCGAGACCTGGCTCTGGAGGCCACGGGCATGATGCTTCGGGTCCTGGTGGGGGCTGTCCTCCCTGCCATGCTACTGGCTGCCC CACCACCCATCAACAAGCTGGCACTGTTCCCAGATAAGAGTGCCTGGTGCGAAGCCAAGAACATCACCCAGATCGTGGGCCACAGCGGCT GTGAGGCCAAGTCCATCCAGAACAGGGCGTGCCTAGGACAGTGCTTCAGCTACAGCGTCCCCAACACCTTCCCACAGTCCACAGAGTCCC TGGTTCACTGTGACTCCTGCATGCCAGCCCAGTCCATGTGGGAGATTGTGACGCTGGAGTGCCCGGGCCACGAGGAGGTGCCCAGGGTGG ACAAGCTGGTGGAGAAGATCCTGCACTGTAGCTGCCAGGCCTGCGGCAAGGAGCCTAGTCACGAGGGGCTGAGCGTCTATGTGCAGGGCG AGGACGGGCCGGGATCCCAGCCCGGCACCCACCCTCACCCCCATCCCCACCCCCATCCTGGCGGGCAGACCCCTGAGCCCGAGGACCCCC >13006_13006_3_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000375142_NBL1_chr1_19981505_ENST00000289749_length(amino acids)=298AA_BP=110 MSDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPS ARLRKLEVEANNAFDQYRDLALEATGMMLRVLVGAVLPAMLLAAPPPINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCF SYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKILHCSCQACGKEPSHEGLSVYVQGEDGPGSQPGTHPHPHP -------------------------------------------------------------- >13006_13006_4_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000375144_NBL1_chr1_19981505_ENST00000289749_length(transcript)=892nt_BP=327nt GAGTGATCAGCAGCTGGACTGTGCCTTGGACCTAATGAGGCGCCTGCCTCCCCAGCAAATCGAGAAAAACCTCAGCGACCTGATCGACCT GGTCCCCAGTCTATGTGAGGATCTCCTGTCTTCTGTTGACCAGCCACTGAAAATTGCCAGAGACAAGGTGGTGGGAAAGGATTACCTTTT GTGTGACTACAACAGAGATGGGGACTCCTATAGGTCACCATGGAGTAACAAGTATGACCCTCCCTTGGAGGATGGGGCCATGCCGTCAGC TCGGCTGAGAAAGCTGGAGGTGGAAGCCAACAATGCCTTTGACCAGTATCGAGACCTGGCTCTGGAGGCCACGGGCATGATGCTTCGGGT CCTGGTGGGGGCTGTCCTCCCTGCCATGCTACTGGCTGCCCCACCACCCATCAACAAGCTGGCACTGTTCCCAGATAAGAGTGCCTGGTG CGAAGCCAAGAACATCACCCAGATCGTGGGCCACAGCGGCTGTGAGGCCAAGTCCATCCAGAACAGGGCGTGCCTAGGACAGTGCTTCAG CTACAGCGTCCCCAACACCTTCCCACAGTCCACAGAGTCCCTGGTTCACTGTGACTCCTGCATGCCAGCCCAGTCCATGTGGGAGATTGT GACGCTGGAGTGCCCGGGCCACGAGGAGGTGCCCAGGGTGGACAAGCTGGTGGAGAAGATCCTGCACTGTAGCTGCCAGGCCTGCGGCAA GGAGCCTAGTCACGAGGGGCTGAGCGTCTATGTGCAGGGCGAGGACGGGCCGGGATCCCAGCCCGGCACCCACCCTCACCCCCATCCCCA >13006_13006_4_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000375144_NBL1_chr1_19981505_ENST00000289749_length(amino acids)=293AA_BP=105 MDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRK LEVEANNAFDQYRDLALEATGMMLRVLVGAVLPAMLLAAPPPINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCFSYSVP NTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKILHCSCQACGKEPSHEGLSVYVQGEDGPGSQPGTHPHPHPHPHPG -------------------------------------------------------------- >13006_13006_5_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000401084_NBL1_chr1_19981505_ENST00000289749_length(transcript)=1028nt_BP=463nt GCCCGGCGCGGGGGGAGGGGGGTGCTGACCCGGATGTTCACTCCTGGGCACCCGGGGAAGTGGAAGCGCCGGGCCCTGCTGCGGGGGGGA GAGCCACTGACGCCGGGACCGGGACCGCCGCCGCCGCCGCCACCATGAGTGATCAGCAGCTGGACTGTGCCTTGGACCTAATGAGGCGCC TGCCTCCCCAGCAAATCGAGAAAAACCTCAGCGACCTGATCGACCTGGTCCCCAGTCTATGTGAGGATCTCCTGTCTTCTGTTGACCAGC CACTGAAAATTGCCAGAGACAAGGTGGTGGGAAAGGATTACCTTTTGTGTGACTACAACAGAGATGGGGACTCCTATAGGTCACCATGGA GTAACAAGTATGACCCTCCCTTGGAGGATGGGGCCATGCCGTCAGCTCGGCTGAGAAAGCTGGAGGTGGAAGCCAACAATGCCTTTGACC AGTATCGAGACCTGGCTCTGGAGGCCACGGGCATGATGCTTCGGGTCCTGGTGGGGGCTGTCCTCCCTGCCATGCTACTGGCTGCCCCAC CACCCATCAACAAGCTGGCACTGTTCCCAGATAAGAGTGCCTGGTGCGAAGCCAAGAACATCACCCAGATCGTGGGCCACAGCGGCTGTG AGGCCAAGTCCATCCAGAACAGGGCGTGCCTAGGACAGTGCTTCAGCTACAGCGTCCCCAACACCTTCCCACAGTCCACAGAGTCCCTGG TTCACTGTGACTCCTGCATGCCAGCCCAGTCCATGTGGGAGATTGTGACGCTGGAGTGCCCGGGCCACGAGGAGGTGCCCAGGGTGGACA AGCTGGTGGAGAAGATCCTGCACTGTAGCTGCCAGGCCTGCGGCAAGGAGCCTAGTCACGAGGGGCTGAGCGTCTATGTGCAGGGCGAGG ACGGGCCGGGATCCCAGCCCGGCACCCACCCTCACCCCCATCCCCACCCCCATCCTGGCGGGCAGACCCCTGAGCCCGAGGACCCCCCTG >13006_13006_5_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000401084_NBL1_chr1_19981505_ENST00000289749_length(amino acids)=298AA_BP=110 MSDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQPLKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPS ARLRKLEVEANNAFDQYRDLALEATGMMLRVLVGAVLPAMLLAAPPPINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCF SYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDKLVEKILHCSCQACGKEPSHEGLSVYVQGEDGPGSQPGTHPHPHP -------------------------------------------------------------- >13006_13006_6_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000433834_NBL1_chr1_19981505_ENST00000289749_length(transcript)=1366nt_BP=801nt TCCCTGTACCTGGGGCGCGCCTTCTTTGCAGCCTTTGGGGAGCGAGGGGAGCTCTCCATCAGGGATGGGGTGGTCCCGGTGCTGTGCCTT CTCAGTTGCCGCTTCTAGGGAGGCCGCCTAGGAGCCAGCGAGGGAAGGGCGGGCATCGGTGTGCCCAGAAGGCAGCGCGCTGCTCTGCGG GCCCTTCTCGAGGCTGCCGCCGTGGGTGCTGTGCGTGCGAAGCATTCTGCAGGGCAGGCCGGGGTCCACGGCGCCCGGGCCTGAGTGGGA GCCGAGGGGCGAGGATGGGTGGCCCACAGGACAAGGATGAACGCACAATCGCCCTTGTGAGGCCGTGGCCTTGGGGGGCCACCAGGCCCT GGATCCAGCATATGGCCTGGACACGATGCACCCAAGCAGGCGCAGCCTCCCCTTCCCTCTGAACTGTCAGCTTGCAAGGGTTGGAACTGC TGATTATGGAAGTCCCTCGGATCAGAGTGATCAGCAGCTGGACTGTGCCTTGGACCTAATGAGGCGCCTGCCTCCCCAGCAAATCGAGAA AAACCTCAGCGACCTGATCGACCTGGTCCCCAGTCTATGTGAGGATCTCCTGTCTTCTGTTGACCAGCCACTGAAAATTGCCAGAGACAA GGTGGTGGGAAAGGATTACCTTTTGTGTGACTACAACAGAGATGGGGACTCCTATAGGTCACCATGGAGTAACAAGTATGACCCTCCCTT GGAGGATGGGGCCATGCCGTCAGCTCGGCTGAGAAAGCTGGAGGTGGAAGCCAACAATGCCTTTGACCAGTATCGAGACCTGGCTCTGGA GGCCACGGGCATGATGCTTCGGGTCCTGGTGGGGGCTGTCCTCCCTGCCATGCTACTGGCTGCCCCACCACCCATCAACAAGCTGGCACT GTTCCCAGATAAGAGTGCCTGGTGCGAAGCCAAGAACATCACCCAGATCGTGGGCCACAGCGGCTGTGAGGCCAAGTCCATCCAGAACAG GGCGTGCCTAGGACAGTGCTTCAGCTACAGCGTCCCCAACACCTTCCCACAGTCCACAGAGTCCCTGGTTCACTGTGACTCCTGCATGCC AGCCCAGTCCATGTGGGAGATTGTGACGCTGGAGTGCCCGGGCCACGAGGAGGTGCCCAGGGTGGACAAGCTGGTGGAGAAGATCCTGCA CTGTAGCTGCCAGGCCTGCGGCAAGGAGCCTAGTCACGAGGGGCTGAGCGTCTATGTGCAGGGCGAGGACGGGCCGGGATCCCAGCCCGG CACCCACCCTCACCCCCATCCCCACCCCCATCCTGGCGGGCAGACCCCTGAGCCCGAGGACCCCCCTGGGGCCCCCCACACAGAGGAAGA >13006_13006_6_CAPZB-NBL1_CAPZB_chr1_19705034_ENST00000433834_NBL1_chr1_19981505_ENST00000289749_length(amino acids)=342AA_BP=154 MGGHQALDPAYGLDTMHPSRRSLPFPLNCQLARVGTADYGSPSDQSDQQLDCALDLMRRLPPQQIEKNLSDLIDLVPSLCEDLLSSVDQP LKIARDKVVGKDYLLCDYNRDGDSYRSPWSNKYDPPLEDGAMPSARLRKLEVEANNAFDQYRDLALEATGMMLRVLVGAVLPAMLLAAPP PINKLALFPDKSAWCEAKNITQIVGHSGCEAKSIQNRACLGQCFSYSVPNTFPQSTESLVHCDSCMPAQSMWEIVTLECPGHEEVPRVDK -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for CAPZB-NBL1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CAPZB-NBL1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CAPZB-NBL1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CAPZB | C0007097 | Carcinoma | 1 | CTD_human |
| Hgene | CAPZB | C0024667 | Animal Mammary Neoplasms | 1 | CTD_human |
| Hgene | CAPZB | C0024668 | Mammary Neoplasms, Experimental | 1 | CTD_human |
| Hgene | CAPZB | C0205696 | Anaplastic carcinoma | 1 | CTD_human |
| Hgene | CAPZB | C0205697 | Carcinoma, Spindle-Cell | 1 | CTD_human |
| Hgene | CAPZB | C0205698 | Undifferentiated carcinoma | 1 | CTD_human |
| Hgene | CAPZB | C0205699 | Carcinomatosis | 1 | CTD_human |
| Hgene | CAPZB | C0948089 | Acute Coronary Syndrome | 1 | CTD_human |
| Hgene | CAPZB | C1257925 | Mammary Carcinoma, Animal | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies